Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2121
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells ; volume:11 ; number:1 ; day:26 ; month:5 ; year:2010 ; pages:1-9 ; date:12.2010
BMC cell biology ; 11, Heft 1 (26.5.2010), 1-9, 12.2010
- Urheber
-
Pan, Pingxi
Fu, Hua
Zhang, Lingjun
Huang, He
Luo, Fengming
Wu, Wenchao
Guo, Yingqiang
Liu, Xiaojing
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2121-11-36
- URN
-
urn:nbn:de:101:1-2021081500534637791583
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pan, Pingxi
- Fu, Hua
- Zhang, Lingjun
- Huang, He
- Luo, Fengming
- Wu, Wenchao
- Guo, Yingqiang
- Liu, Xiaojing
- SpringerLink (Online service)
Ähnliche Objekte (12)
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
A novel kartogenin-platelet-rich plasma gel enhances chondrogenesis of bone marrow mesenchymal stem cells in vitro and promotes wounded meniscus healing in vivo
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
CAR-T Cell Therapy: Advances in Kidney-Related Diseases
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
A novel kartogenin-platelet-rich plasma gel enhances chondrogenesis of bone marrow mesenchymal stem cells in vitro and promotes wounded meniscus healing in vivo
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
CAR-T Cell Therapy: Advances in Kidney-Related Diseases
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
A novel kartogenin-platelet-rich plasma gel enhances chondrogenesis of bone marrow mesenchymal stem cells in vitro and promotes wounded meniscus healing in vivo
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
CAR-T Cell Therapy: Advances in Kidney-Related Diseases
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy